Literature DB >> 9647033

P53 protein immunohistochemical expression in colonic adenomas with and without associated carcinoma.

H A Saleh1, A Aburashed, P Bober, P Tabaczka.   

Abstract

OBJECTIVES: P53 protein immunohistochemical (IHC) expression was investigated in a series of colonic adenomas and carcinomas to determine the p53 immunohistochemical expression of adenomas in general compared with carcinomas, the difference in staining pattern between adenomas with associated carcinoma and those without associated carcinoma, and the difference in p53 staining in the usual adenomas (low-grade dysplasia) compared with those harboring high-grade dysplasia.
METHODS: The study involved a series of 20 adenomas without concurrent carcinoma (group 1 adenoma), 29 adenomas with concurrent carcinoma (group 2 adenoma), and 20 carcinomas. Sections of the paraffin-embedded tissues were stained with DO-7 p53 monoclonal antibody after microwave antigen-retrieval method. Cases with nuclear staining in > or = 20% of the tumor cells were considered positive.
RESULTS: Analysis of results showed that 65% of carcinomas and 37% of all adenomas were reactive with p53 IHC staining (p = 0.03). With respect to the adenomas, 30% of group 1 and 41% of group 2 adenomas were reactive for p53 protein (p = 0.42).
CONCLUSIONS: Our data demonstrate a statistically significant higher p53 expression rate in colonic carcinomas than in adenomas, and that adenomas with concurrent carcinomas are more frequently p53 positive than those without concurrent carcinoma, but this was not statistically significant. Also, p53 expression is more frequent and intense in adenomas with high-grade dysplasia (10/20, 50%) than in ordinary adenomas with low-grade dysplasia (8/29, 28%), which suggests a strong correlation between the degree of dysplasia in colonic neoplasia and p53 expression pattern.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647033     DOI: 10.1111/j.1572-0241.1998.00292.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Expression of Gastric Markers Is Associated with Malignant Potential of Nonampullary Duodenal Adenocarcinoma.

Authors:  Chihiro Minatsuki; Nobutake Yamamichi; Ken-Ichi Inada; Yu Takahashi; Kouhei Sakurai; Takeshi Shimamoto; Yosuke Tsuji; Kazuya Shiogama; Shinya Kodashima; Yoshiki Sakaguchi; Keiko Niimi; Satoshi Ono; Toru Niwa; Ken Ohata; Nobuyuki Matsuhashi; Masao Ichinose; Mitsuhiro Fujishiro; Yutaka Tsutsumi; Kazuhiko Koike
Journal:  Dig Dis Sci       Date:  2018-06-28       Impact factor: 3.199

2.  Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

Authors:  Janine G Einspahr; Maria Elena Martinez; Ruiyun Jiang; Chiu-Hsieh Hsu; Asif Rashid; Achyut K Bhattacharrya; Dennis J Ahnen; Elizabeth T Jacobs; P Scott Houlihan; C Renee Webb; David S Alberts; Stanley R Hamilton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

3.  No major difference in K-ras and p53 abnormalities in sporadic and hereditary nonpolyposis colorectal adenomas.

Authors:  D W Voskuil; E Kampman; W van Geloof; M Grubben; F Kok; G van Muijen; F Nagengast; H Vasen; P van't Veer
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

4.  Somatic Mutations in Exon 7 of the TP53 Gene in Index Colorectal Lesions Are Associated with the Early Occurrence of Metachronous Adenoma.

Authors:  Tereza Hálková; Renata Ptáčková; Anastasiya Semyakina; Štěpán Suchánek; Eva Traboulsi; Ondřej Ngo; Kateřina Hejcmanová; Ondřej Májek; Jan Bureš; Miroslav Zavoral; Marek Minárik; Lucie Benešová
Journal:  Cancers (Basel)       Date:  2022-06-07       Impact factor: 6.575

5.  Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomas.

Authors:  Rafiq A Sheikh; Byung Hee Min; Shagufta Yasmeen; Raymond Teplitz; Henry Tesluk; Boris Henry Ruebner; Martin Tobi; James Hatfield; Suzanne Fligiel; Michael J Lawson
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

6.  Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression.

Authors:  Soulafa Mamlouk; Tincy Simon; Laura Tomás; David C Wedge; Alexander Arnold; Andrea Menne; David Horst; David Capper; Markus Morkel; David Posada; Christine Sers; Hendrik Bläker
Journal:  BMC Biol       Date:  2020-09-07       Impact factor: 7.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.